Assessing Perrigo (PRGO) Valuation After Recent Share Price Rebound

Simply Wall St.01-10

Perrigo (PRGO) has attracted fresh attention after recent trading, with the share price at $14.70 and mixed return figures across different periods. This is prompting investors to reassess what they ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2602306175?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","is_english":true,"pubTime":"2026-01-10 02:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2602306175","market":"nz","top_or_hot":-1,"title":"Assessing Perrigo (PRGO) Valuation After Recent Share Price Rebound","media":"Simply Wall St.","content":"<div>\n<p>Perrigo (PRGO) has attracted fresh attention after recent trading, with the share price at $14.70 and mixed return figures across different periods. This is prompting investors to reassess what they ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-prgo/perrigo/news/assessing-perrigo-prgo-valuation-after-recent-share-price-re\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Assessing Perrigo (PRGO) Valuation After Recent Share Price Rebound</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAssessing Perrigo (PRGO) Valuation After Recent Share Price Rebound\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-01-10 02:43 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-prgo/perrigo/news/assessing-perrigo-prgo-valuation-after-recent-share-price-re><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Perrigo (PRGO) has attracted fresh attention after recent trading, with the share price at $14.70 and mixed return figures across different periods. This is prompting investors to reassess what they ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-prgo/perrigo/news/assessing-perrigo-prgo-valuation-after-recent-share-price-re\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PRGO","symbol_name":"百利高","start_time":0,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-prgo/perrigo/news/assessing-perrigo-prgo-valuation-after-recent-share-price-re","article_id":"2602306175","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-prgo/perrigo/news/assessing-perrigo-prgo-valuation-after-recent-share-price-re","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2602306175","pubTimestamp":1767984189,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Perrigo (PRGO) has attracted fresh attention after recent trading, with the share price at $14.70 and mixed return figures across different periods. This is prompting investors to reassess what they are paying for its self care portfolio.\nSee our latest analysis for Perrigo.\nRecent trading has lifted Perrigo’s short term momentum, with a 7 day share price return of 5.6% and 30 day share price return of 10.36%. However, the 1 year total shareholder return of 38% and 5 year total shareholder...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"PRGO":"百利高","BK4007":"制药","IE00BFMHRM44.USD":"NEUBERGER BERMAN GLOBAL EQUITY MEGATRENDS \"A\" (USD) ACC"},"translate_title":"近期股价反弹后评估Perrigo(PRGO)的估值","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PRGO":1.5},"content_text":"Perrigo (PRGO) has attracted fresh attention after recent trading, with the share price at $14.70 and mixed return figures across different periods. This is prompting investors to reassess what they are paying for its self care portfolio. See our latest analysis for Perrigo. Recent trading has lifted Perrigo’s short term momentum, with a 7 day share price return of 5.6% and 30 day share price return of 10.36%. However, the 1 year total shareholder return of 38% and 5 year total shareholder return of 60.61% point to a much tougher longer term picture. If Perrigo’s recent rebound has you reassessing your portfolio, it could be a good time to scan healthcare stocks for other health focused names that fit your criteria. With Perrigo trading at $14.70 against an analyst price target of $21.00 and an indicated intrinsic discount of 79%, the question is simple: is this a genuine value opportunity, or is the market already pricing in future growth? AdvertisementMost Popular Narrative: 30% Undervalued The most followed narrative places Perrigo’s fair value at US$21.00 versus the last close of US$14.70, framing a sizeable valuation gap for investors to weigh. Ongoing operational initiatives like Project Energize and supply chain reinvention are generating US$150M to US$200M in savings, funding innovation and margin-accretive investments, which are expected to further improve gross margins and net earnings over time. Read the complete narrative. Curious what kind of revenue runway and margin reset are baked into that US$21.00 fair value, and how rich the implied P/E becomes by the forecast horizon? The full narrative lays out the earnings climb, the profitability shift, and the valuation multiple that needs to hold for this upside case to work. Result: Fair Value of $21.00 (UNDERVALUED) Have a read of the narrative in full and understand what's behind the forecasts. However, softer over the counter demand and a slower infant formula recovery, including legal and category uncertainties, could easily derail the upbeat valuation story. Find out about the key risks to this Perrigo narrative.  Build Your Own Perrigo Narrative If you see the story differently or prefer to test the assumptions yourself, you can reshape the inputs and build a fresh thesis in minutes: Do it your way A great starting point for your Perrigo research is our analysis highlighting 3 key rewards and 1 important warning sign that could impact your investment decision. Ready for more investment ideas? Do not stop with just one stock. Use the Simply Wall St Screener to uncover fresh ideas that fit your style and keep your watchlist working harder.  Target potential bargains by scanning these 878 undervalued stocks based on cash flows and see which companies currently trade at prices that may not fully reflect their underlying cash flows. Tap into powerful technology trends by checking out these 28 AI penny stocks and see which businesses are tied to artificial intelligence themes that interest you. Build a cash flow focused portfolio by reviewing these 11 dividend stocks with yields > 3% that combine income potential with yields above 3%.   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2602306175","isCrawlerRequest":true}